Atria Wealth Solutions’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$4.78M Sell
195,671
-381,972
-66% -$8.91M 0.11% 218
2025
Q1
$14.6M Sell
577,643
-7,320
-1% -$192K 0.18% 126
2024
Q4
$15.5M Buy
584,963
+7,544
+1% +$205K 0.17% 124
2024
Q3
$16.7M Buy
577,419
+27,324
+5% +$797K 0.18% 119
2024
Q2
$15.4M Buy
550,095
+53,295
+11% +$1.47M 0.17% 126
2024
Q1
$13.8M Buy
496,800
+17,201
+4% +$477K 0.16% 143
2023
Q4
$13.8M Sell
479,599
-16,994
-3% -$514K 0.17% 125
2023
Q3
$16.5M Sell
496,593
-29,683
-6% -$1.05M 0.23% 97
2023
Q2
$19.3M Buy
526,276
+25,806
+5% +$1M 0.26% 80
2023
Q1
$20.4M Sell
500,470
-11,434
-2% -$494K 0.3% 75
2022
Q4
$26.2M Buy
511,904
+12,851
+3% +$616K 0.42% 41
2022
Q3
$21.8M Buy
499,053
+261,471
+110% +$12.7M 0.38% 49
2022
Q2
$26.1M Sell
237,582
-209,299
-47% -$10.7M 0.49% 39
2022
Q1
$23.1M Buy
+446,881
New +$23.2M 0.38% 47

Other funds holding PFE

Atria Wealth Solutions's PFE Position: Q2 2025 in Review

Atria Wealth Solutions reduced its Pfizer (PFE) stake by 66% in Q2 2025, selling an estimated $8.91M and leaving 195,671 shares worth $4.78M. The position accounts for 0.11% of the portfolio, ranked #218.

Atria Wealth Solutions first reported a position in PFE in Q1 2022 and has held it in 14 quarters since. The position peaked at $26.2M in Q4 2022. 2,813 funds tracked by Wall St. Rank hold PFE as of Q2 2025.

  • Atria Wealth Solutions held 195,671 shares of Pfizer worth $4.78M as of Q2 2025.
  • Atria Wealth Solutions sold 381,972 Pfizer shares in Q2 2025, an estimated $8.91M.
  • Pfizer made up 0.11% of Atria Wealth Solutions's portfolio in Q2 2025, its #218 holding.
  • Atria Wealth Solutions first reported a position in Pfizer in Q1 2022 and has held it in 14 quarters since.
  • Atria Wealth Solutions's Pfizer position peaked at $26.2M in Q4 2022.
  • 2,813 funds tracked by Wall St. Rank held Pfizer as of Q2 2025.

Based on Atria Wealth Solutions's 13F filing for Q2 2025, filed 25 Jul 2025.